TreatmentTreatment if toxicity persists after dose reduction to 1 mg neutropenia
Generic name: Pomalidomide
Brand name: Bolemide
Dosage form: Capsules.
is a for patients with multiple therapies , , Disease progression was confirmed treatment .
Dosage and Administration
: pomalidomide mg orally per day of 28 days
with 40 mg on 1 8 , 15, and 22 of each
For 75-year-olds, the initial dose of 1 , 8, 15, and 22
0mg each time.
2. Dosage Form Specifications
● Capsules, mg, mg. 3. Contraindications: .
Warnings and Precautions
Hematologic : The most event . patients for toxicity , .
• Hepatotoxicity: Liver failure .
● : and dermatological have been reported .
severe reactions .
syndrome (TLS ) : monitor at risk TLS , patients with
Most common adverse reactions ( 30%) fatigue, , , , , , , dyspnea, , and